Skip to main content
. 2017 Nov 21;8(64):107666–107677. doi: 10.18632/oncotarget.22587

Figure 5. Low expression of YAP1 mRNA in tumor tissues predicted good prognosis in GC.

Figure 5

(A) Overall survival rate of patients with GC according to YAP1 mRNA expression in tumor tissues in three independent datasets (left: Kyushu dataset, middle: Singapore dataset, right: Kaplan-Meier dataset). (B) A proposed model showing how ivermectin inhibits YAP1 expression and suppresses tumor growth in GC.